Peripheral administration of hypothalamic peptides results in CNS changes.

No abstract is available for this paper.

• Publication year

  1978

• Venue

  Pharmacological Research Communications

• Publication date

  1978-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0031-6989(78)80025-3PMID 28532
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influence of vasopressin on learning and memory.

  1978cited by this paper
• Vasopressin in amnesia.

  1978cited by this paper
• Natriuresis after water loading in rats bearing transplants of pars intermedia

  1977cited by this paper
• β-endorphin: Dose-dependent suppression of fixed-ratio operant behavior

  1977cited by this paper
• Antagonism of the analeptic activity of thyrotropin-releasing hormone (TRH) by agents which enhance GABA transmission

  1977cited by this paper
• Comparison of thyrotropin-releasing hormone with melanocyte-stimulating-hormone-release-inhibiting factor as pentobarbital antagonists in monkeys

  1977cited by this paper
• Characterization of a delta-electroencephalogram (-sleep)-inducing peptide.

  1977cited by this paper
• MSH/ACTH4-10 influences on the CAR in human subjects: a negative finding.

  1977cited by this paper
• Psychoendocrinological and therapeutic effects of TRH in depression

  1977cited by this paper
• Lack of effect of chronically administered thyrotropin-releasing hormone (TRH) on regional rat brain tyrosine hydroxylase activity.

  1977cited by this paper
• Endorphin analogs with potent and long-lasting analgesic effects.

  1977cited by this paper
• beta-endorphin: synthesis and morphine-like activity of analogs with D-amino acid residues in positions 1, 2, 4, and 5.

  1977cited by this paper
• Enhancement of locomotor activity and catecholamine and 5-hydroxytryptamine metabolism by thyrotropin releasing hormone.

  1977cited by this paper
• How ACTH acts on the brain

  1977cited by this paper
• Synthetic MIF analogues. Part II: Dopa potentiation and fluphenazine antagonism.

  1977cited by this paper
• Beta-endorphin and male sexual behavior.

  1977cited by this paper
• β-Endorphin-Induced Changes in Schizophrenic and Depressed Patients

  1977cited by this paper
• Breakdown of enkephalin and endorphin analogs by brain extracts.

  1977cited by this paper
• β-Endorphin and male sexual behavior

  1977cited by this paper
• Beta-endorphin: dose-dependent suppression of fixed-ratio operant behavior.

  1977cited by this paper
• Putative peptide neurotransmitters.

  1977cited by this paper
• MSH/ACTH 4-10 influences behavioral and physiological measures of attention.

  1977cited by this paper
• Inactivation of thyrotrophin releasing hormone by human and rat serum.

  1977cited by this paper
• Peptides with Morphine-like Action in the Brain

  1977cited by this paper
• Thyrotropin‐Releasing Hormone (TRH) in chronic schizophrenia: A CONTROLLED STUDY

  1977cited by this paper
• Studies on the influence of biogenic amines and psychoactive drugs on the prognostic value of the TRH stimulation test in endogenous depression.

  1977cited by this paper
• Comparison of the regulation of rotational behavior by hypothalamic oligopeptides.

  1977cited by this paper
• Neurotensin: central nervous system effects of a hypothalamic peptide.

  1977cited by this paper
• On the optimal dosage of Pro-Leu-Gly-NH2 (MIF) in neuropharmacological tests and clinical use

  1977cited by this paper
• Influence of neonatal injections of α-MSH on learning, memory and attention in rats

  1977cited by this paper
• Neurotransmitters and hypothalamic hormones in the central nervous system.

  1977cited by this paper
• Regional distribution of LEU and MET enkephalin in rat brain.

  1977cited by this paper
• Thyroid stimulating hormone response after thyrotropin releasing hormone in depressed, schizophrenic and normal women.

  1977cited by this paper
• Local degradation of growth hormone-release-inhibiting hormone (somatostatin) in the central nervous system.

  1977cited by this paper
• An analog of enkephalin having prolonged opiate-like effects in vivo.

  1977cited by this paper
• Beta-endorphin--induced changes in schizophrenic and depressed patients.

  1977cited by this paper
• Influence of neonatal injections of alpha-MSH on learning, memory and attention in rats.

  1977cited by this paper
• Brain peptides with opiate antagonist action: their possible role in tolerance and dependence.

  1977cited by this paper
• Inactivation of thyrotrophin releasing hormone (TRH) by peptidases in different areas of the rabbit brain.

  1976cited by this paper
• A DOUBLE BLIND CROSS OVER TRIAL OF GONADOTROPHIN RELEASING HORMONE (LHRH) IN SEXUALLY IMPOTENT MEN

  1976cited by this paper
• Neuropharmacological actions of enkephalin after systemic administration.

  1976cited by this paper
• Substance P and analgesia

  1976cited by this paper
• Induction of excessive grooming in the rat by fragments of lipotropin

  1976cited by this paper
• Distribution of 3H-alpha-MSH in rat brain.

  1976cited by this paper
• Blood-brain barrier, half-time disappearance, and brain distribution for labeled enkephalin and a potent analog.

  1976cited by this paper
• Melanin in the rat brain.

  1976cited by this paper
• Investigations into the mechanism of reduction of ethanol sleep by thyrotropin-releasing hormone (TRH).

  1976cited by this paper
• Enkephalin and a potent analog facilitate maze performance after intraperitoneal administration in rats.

  1976cited by this paper
• Influence of three short-chain peptides (alpha-MSH, MSH/ACTH 4-10, MIF-I on) dimensional attention.

  1976cited by this paper
• Neuropeptide MSH/ACTH 4-10 enhances attention in the mentally retarded.

  1976cited by this paper
• Peptides readily penetrate the blood-brain barrier: uptake of peptides by synaptosomes is passive.

  1976cited by this paper
• Antagonism of isolation-induced aggression in mice by thyrotropin-relasing hormone (TRH).

  1976cited by this paper
• Some questions related to melanocyte-stimulating hormone.

  1976cited by this paper
• Neuroheptapeptide influence on attention and memory in man.

  1976cited by this paper
• Hypothalamic releasing factors: physiological evidence for a regulatory action on central neurons and pathways for their distribution in brain.

  1976cited by this paper
• Effects of L-prolyl-L-leucyl-glycine amide (MIF-I) on dopaminergic neurons.

  1976cited by this paper
• Differences in the degradation of hypothalamic releasing factors by rat and human serum.

  1976cited by this paper
• (D-Ala2)-Met-enkephalinamide: a potent, long-lasting synthetic pentapeptide analgesic.

  1976cited by this paper
• Somatostatin and thyrotropin releasing hormone: central effect on sleep and motor system.

  1976cited by this paper
• Synthesis and opioid activities of stereoisomers and other D-amino acid analogs of methionine-enkephalin.

  1976cited by this paper
• Investigations on alpha-MSH and MIF-1 effects on cyclic AMP levels in rat brain.

  1976cited by this paper
• Effects of alpha-MSH on motivation, vigilance and brain respiration.

  1976cited by this paper
• Thyrotropin-releasing hormone: differential antidepressant and endocrinological effects.

  1976cited by this paper
• Neuropharmacological tests with alpha-melanocyte stimulating hormone.

  1976cited by this paper
• Endorphins: profound behavioral effects in rats suggest new etiological factors in mental illness.

  1976cited by this paper
• Comparison of the analeptic potency of TRH, ACTH 4-10, LHRH, and related peptides.

  1976cited by this paper
• Biodegradation of alpha-MSH and derived peptides by rat brain extracts, and by rat and human serum.

  1976cited by this paper
• Clinical investigations for emotional effects of neuropeptide hormones.

  1976cited by this paper
• The C-fragment of beta-lipotropin: an endogenous neuroleptic or antipsychotogen?

  1976cited by this paper
• Neonatal treatment with TRH affects development, learning, and emotionality in the rat.

  1976cited by this paper
• Effects of α-MSH on motivation, vigilance and brain respiration☆

  1976cited by this paper
• Biodegradation of α-MSH and derived peptides by rat brain extracts, and by rat and human serum

  1976cited by this paper
• Influence of three short-chain peptides (α-MSH, MSH/ACTH 4–10, MIF-I on) dimensional attention

  1976cited by this paper
• Dorsal hippocampus: a site of action of neuropeptides on avoidance behavior?

  1976cited by this paper
• Investigations on α-MSH and MIF-I effects on cyclic AMP levels in rat brain ☆

  1976cited by this paper
• Neuropharmacological tests with α-melanocyte stimulating hormone

  1976cited by this paper
• Distribution of 3H-α-MSH in rat brain

  1976cited by this paper
• Letter: Survival in Wilms' tumour.

  1975cited by this paper
• Potentiation of levodopa effect by intravenous L-prolyl-L-leucyl-glycine amide in man.

  1975cited by this paper
• Somatostatin: abundance of immunoreactive hormone in rat stomach and pancreas.

  1975cited by this paper
• Increased acquisition of a complex appetitive task after MSH and MIF.

  1975cited by this paper
• Effect of hypothalamic deafferentation on thyrotropin-releasing hormone levels in rat brain.

  1975cited by this paper
• Protirelin stimulation test and thyroid function during treatment of depression.

  1975cited by this paper
• The regional distribution of somatostatin in the rat brain.

  1975cited by this paper
• Identification of two related pentapeptides from the brain with potent opiate agonist activity

  1975cited by this paper
• Prostaglandin levels in tissues of the male reproductive system in six strains of mice.

  1975cited by this paper
• Enhancement of attention in man with ACTH/MSH 4-10.

  1975cited by this paper
• Localization of growth hormone-release-inhibiting hormone (somatostatin) in the rat brain.

  1975cited by this paper
• α-MSH and MIF-I effects on catecholamine levels and synthesis in various rat brain areas☆

  1975cited by this paper
• [Infusion therapy with mif (melanocyte inhibiting factor) in Parkinson's disease (author's transl)].

  1975cited by this paper
• Sexual impotence: a double-blind study of LHRH nasal spray versus placebo.

  1975cited by this paper
• Significant Differences in the Degradation of Pro-Leu-Gly-NH2 by Human Serum and that of Other Species 1

  1975cited by this paper
• Inactivation of somatostatin (GH‐RIH) and its analogs by crude and partially purified rat brain extracts

  1975cited by this paper
• Modification of pentobarbital effects by natural and synthetic polypeptides: dissociation of brain and pituitary effects.

  1975cited by this paper
• Neurohypophyseal hormones, analogs, and fragments: their effect on puromycin-induced amnesia.

  1975cited by this paper
• Central nervous system effects of hypothalamic peptides.

  1975cited by this paper
• Letter: inadequate mothers.

  1975cited by this paper
• MSH affects regional perfusion of the brain.

  1975cited by this paper
• Intensification of central catecholaminergin and serotonergic processes by the hypothalamic factors MIF and TRF and by angiotensin II.

  1975cited by this paper
• Pharmacological studies with a tripeptide, prolyl-leucyl glycine amide.

  1974cited by this paper

• Endocrine approaches to treatment of Alzheimer's disease and other neurological conditions: Part I: Some recollections of my association with Dr. Abba Kastin: A tale of successful collaboration.

  2015cites this paper
• Abba Kastin: The melanocyte stimulating hormone story and the future of the proteophathies.

  2015cites this paper
• Blood-brain barrier as a regulatory interface.

  2010cites this paper
• Concepts for biologically active peptides.

  2010cites this paper
• Evolution of neuropeptide concepts illustrated by MIF-1 and MSH

  2009cites this paper
• Permeability of the Blood—Brain Barrier to Neurotrophic Peptides

  2006cites this paper
• Antiaging methods and medicines for the memory.

  2004cites this paper
• Effects of the novel compound aniracetam (Ro 13-5057) upon impaired learning and memory in rodents

  2004cites this paper
• Is obesity a disease of the blood-brain barrier? Physiological, pathological, and evolutionary considerations.

  2003cites this paper
• Neuroendocrine control of growth hormone secretion.

  1999cites this paper
• Methodologic Issues in the Measurement of Oxytocin in Human Neonates

  1998cites this paper
• Neuropeptides and human sleep.

  1997cites this paper
• [Sleep endocrinology].

  1995cites this paper
• Effects of growth hormone-releasing hormone and somatostatin on sleep EEG and nocturnal hormone secretion in male controls.

  1992cites this paper
• Effects of an ACTH/MSH(4-9) analog (HOE 427) on the sleep EEG and nocturnal hormonal secretion in humans.

  1991cites this paper
• A Decade of Changing Perceptions about Neuropeptides

  1990cites this paper
• Stress-induced analgesia: adaptive pain suppression.

  1986cites this paper
• Hypoinsulinemic and Hyperglycemic Effects of β-Endorphin in Rabbits

  1986cites this paper
• Childhood autism: a complex disorder.

  1986cites this paper
• Sleep-wave activity of a delta sleep-inducing peptide analog correlates with its penetrance of the blood-brain barrier.

  1986cites this paper
• Role of Circulating Opioids in the Modulation of Pain a

  1986cites this paper
• Effects of Pro-Opiomelanocortin-Derived Peptides on Plasma Levels of Glucagon, Insulin and Glucose

  1986cites this paper
• Neuropeptide therapies in chronic schizophrenia: TRH and vasopressin administration.

  1986cites this paper
• Iron deficiency induces reversal of dopamine dependent circadian cycles: differential response to d-amphetamine and TRH.

  1985cites this paper
• Blood—Brain Barrier and Peptides

  1985cites this paper
• Involvement of the Autonomic Nervous System in the In Vivo TRH-Induced Increases in the Plasma Levels of Glucagon, Insulin and Glucose in Rabbits

  1985cites this paper
• Urinary peptides in schizophrenia and depression

  1985cites this paper
• Chlordiazepoxide-induced potentiation of hexobarbitone sleeping time is reduced by ACTH(1-24).

  1984cites this paper
• Tyr-MIF-1 and MIF-1 are active in the water wheel test for antidepressant drugs.

  1984cites this paper
• Alpha-melanocyte stimulating hormone increases plasma levels of glucagon and insulin in rabbits.

  1984cites this paper
• Evidence that [125I]N-Tyr-delta sleep-inducing peptide crosses the blood-brain barrier by a non-competitive mechanism.

  1984cites this paper
• Delta-sleep-inducing peptide (DSIP): a review.

  1984cites this paper
• Brain peptides: The dangers of constricted nomenclatures

  1983cites this paper
• Centrally mediated effects of neurohypophyseal hormones.

  1983cites this paper
• LHRH and rat avoidance behavior: influence of castration and testosterone.

  1983cites this paper
• Minireview. Brain peptides: the dangers of constricted nomenclatures.

  1983cites this paper
• Desglycyl-8-arginine vasopressin affects regional mouse brain cyclic AMP content.

  1982cites this paper
• The opiomelanotropinergic neuronal and endocrine systems.

  1982cites this paper
• Effects of TRH and PS-24 on colonic temperature and motor activity of rats: possible role of dopamine.

  1981cites this paper
• Extrahypothalamic distributions and functions of hypothalamic peptide hormones.

  1981cites this paper
• [Effects of cerebral, hypothalamic and hypophyseal peptides on the central nervous system].

  1981cites this paper
• Mu and delta opiate receptors in rat brain are affected by GTP but not by MIF-1.

  1981cites this paper
• Inverse relationship between onset and duration of EEG effects of six peripherally administered peptides.

  1981cites this paper
• Behavioral effects of LH-RH.

  1980cites this paper
• A theory of convulsive therapy in endogenous depression: significance of hypothalamic functions.

  1980cites this paper
• Neuroendocrinology and ECT: a review of recent developments.

  1980cites this paper
• A neuroendocrine theory of convulsive therapy

  1980cites this paper
• ECT, mood and hormones

  1980cites this paper
• Extending the duration of ACTH-induced memory reactivation in an amnesic paradigm.

  1980cites this paper
• Effects of an enkephalin analog on complex learning in the rhesus monkey.

  1979cites this paper
• A comparison of central and hormal effects of peptides related to thyroliberin (TRH) and melanostatin (MIF).

  1979cites this paper
• Radioimmunoassay of DSIP-like material in rat brain.

  1978cites this paper
• Neuropeptides and the blood-brain barrier in goldfish.

  1978cites this paper
• Activity of VIP, somatostatin and other peptides in the mouse vas deferens assay.

  1978cites this paper
• Disappearance and excretion of labeled α-MSH in man☆

  1978cites this paper
• Enkephalin and other peptides reduce passiveness.

  1978cites this paper
• Disapearance and excretion of labeled alpha-MSH in man.

  1978cites this paper